Richard Ha, MD
Plastic and Reconstructive Surgery · Dallas, TXNPI 1609849207
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Synthes GmbH at 39.5% of the total. Reporting peaked in 2019 at $12,440 and has fallen 98.8% since, to $148 in 2025.
Across 111 payments — averaging $152.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$7K
- Sientra, Inc.$3K
- Kls-martin L.p.$3K
- AbbVie$954
- Mentor Worldwide LLC$837
- Johnson & Johnson$634
- plus $2K from 9 others
Across 1 payment — averaging $43,441 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GE HealthCare$43K
What the payments were for
- Consulting fees$2,71016%
- Speaking & faculty fees$4,00024%
- Travel & lodging$3,31820%
- Food & beverage$6,85041%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 6 | $6,664 |
| Sientra, Inc. | 9 | $3,272 |
| Kls-martin L.p. | 21 | $2,680 |
| AbbVie(2 entities) | 23 | $954 |
| Mentor Worldwide LLC | 19 | $837 |
| Johnson & Johnson | 10 | $634 |
| Tepha Inc | 6 | $606 |
| Musculoskeletal Transplant Foundation Inc. | 7 | $462 |
| Bard Peripheral Vascular, Inc. | 3 | $249 |
| TELA Bio, Inc. | 1 | $175 |
| Davol Inc. | 1 | $152 |
| Merz North America, Inc. | 2 | $118 |
| Pacira Pharmaceuticals Incorporated | 1 | $33 |
| Smith+Nephew | 1 | $27 |
| Galderma Laboratories, L.p. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,878 in reported general payments places this provider in the 85th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $202 |
| Cephalexin | 39 | $171 |
| Diazepam | 12 | $48 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Dallas
- Ben TittleDallas$73K
- Jennifer KargelDallas$17K
- Solomon AzouzDallas$16K
- Bradley HubbardDallas$14K
- Jeffrey KenkelDallas$12K
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
- Patrick GarveyHouston$117K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.